PFE : Analysis & Opinions

  • Showing 1-100 of 184 items
  • 1
  • 2
  • >>
  1. Even a 15% Tax Rate May Not Help Pharmaceuticals

    January 19, 2017
    Will a lower corporate tax rate help bring more profit to the industry? They may already be doing it on their own.
  2. PFE Not the Only Pharma Co. Hurt by Strong Dollar

    January 18, 2017
    Today the Financial Times reported that Pfizer (and by implication other pharmaceutical companies) may be impacted by a strong ...
  3. In This Case Silence Could be Golden

    January 17, 2017
    Healthcare stocks are falling again ahead of Friday's transition of power.
  4. These 5 Drug Patents Will Expire in 2017

    January 16, 2017
    Investopedia looks at the top drug patents about to expire in 2017
  5. Dogs of the Dow: Why 2017 Might Be Their Year

    January 11, 2017
    With all eyes focused on the Dow's recent rally, there is one investment strategy that couldn't care less.
  6. Healthcare Slammed As Trump Vows To Fight Drug Prices

    January 11, 2017
    Today President-Elect Trump once again stated he wants to take on drug pricing.
  7. Hot Dividend-Growth Stocks for 2017 (PFE, GT)

    January 11, 2017
    Interest rate increases can scare stock investors, but these dividend-growth stocks may give you reason to continue to invest.
  8. Piper Bullish On Pfizer and Eli Lilly

    January 9, 2017
    Today, Piper mentioned that it likes Pfizer and Eli Lilly and is less a favorable on Merck and Johnson & Johnson.
  9. Biosimilar Drugs To Take On Top Brand Names

    January 4, 2017
    Makers of biosimilar drugs may erode the market share of top brand names as competition heats up.
  10. Pharma M&A Boom Expected from 'Trump Tax Holiday'

    January 3, 2017
    Trump's proposed tax holiday may cause a boom in drug mergers, leading to potential job losses.
  11. Mega Deals: Why the Outlook Is Uncertain

    January 2, 2017
    The global M&A landscape could change in 2017 as new policies could hinder deal making.
  12. Healthcare Stocks Struggled in 2016

    December 30, 2016
    Healthcare stocks struggled all year. Things may be looking up in the new year.
  13. Does Pfizer Acquisition From AZN Help The Stock?

    December 23, 2016
    Pfizer completes the a purchase from AstraZeneca for it late-stage small molecule anti-infective business.
  14. European Regulator Approves Pfizer Vaccine

    December 19, 2016
    Pfizer announced today its vaccine Nimenrix has been approved in Europe.
  15. Report on PFE and JNJ Are Moving the Stocks Higher

    December 12, 2016
    A positive article on Johnson & Johnson and a Pfizer dividend increase are boosting their shares, and the group higher.
  16. Pfizer Up Along with Other Healthcare Stocks

    December 9, 2016
    Pfizer, along with Akili Interactive, reported positive data that could help with the detection of onset Alzheimer's disease.
  17. The UK Has Fined PFE For Unfair Drug Pricing (PFE)

    December 7, 2016
    The company was fined for its unfair practices and pricing.
  18. How China Makes Money (BABA, PFE)

    December 2, 2016
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  19. IBM, Pfizer Announce Partnership (IBM, PFE)

    December 1, 2016
    International Business Machines Corp. and Pfizer Inc. have announced a partnership to accelerate immuno-oncology research.
  20. Lyrica Showed Efficacy in Children With Epilesey (PFE)

    December 1, 2016
    Pfizer Inc. reported positive phase 3 results for Lyrica in children with epilepsy.
  21. Pfizer reports positive REFLECTIONS data (PFE)

    November 30, 2016
    Pfizer Inc. reported positive results for its Herceptin biosimiliar
  22. Drugmakers' Price Duopoly (PFE, LLY)

    November 30, 2016
    Legislators are becoming more and more concerned that many big drugmakers are boosting prices in tandem.
  23. Pfizer Shares up in Early Trading (PFE)

    November 29, 2016
    Pfizer received an upgrade from Barclay's and receiving a priority review from the FDA.
  24. Pfizer Nixes 350-Job Expansion After Drug Fails (PFE)

    November 28, 2016
    The U.S. pharmaceutical giant canceled a €400 million expansion of its Dublin plant that would have created 350 permanent ...
  25. Big Pharma Battles over Psoriasis Market (NVS, CELG)

    November 17, 2016
    Major drug makers are battling for dominance of the lucrative psoriatic arthritis drug space.
  26. Pfizer Pneumonia Drug Price Slashed for Charity (PFA)

    November 14, 2016
    Pfizer reduced the price of its Prevenar 13 pneumonia vaccine to poor countries, under pressure from humanitarian groups.
  27. Pfizer May Sell, Spin Off Consumer Health Op (PFE)

    November 11, 2016
    Pfizer may sell or spin off its Consumer Health unit for $14 billion.
  28. Drug Stocks Rebound After Clinton Defeat (PFE, MRK)

    November 10, 2016
    Drug and biotech stocks rebounded sharply after the Trump victory. Hillary Clinton had pledged to stop escalating prices, ...
  29. These Charts Suggest Health Care Stocks Are Headed Lower

    November 9, 2016
    The recent close below a key level of support on the chart of exchange-traded funds such as XLV suggests that prices are ...
  30. Bonuses on Wall Street to Take a Dive (DOW, PFE)

    November 7, 2016
    Poor fund returns and stalled mergers have caused bonuses on Wall Street to decline for the third year in a row.
  31. Pfizer Scraps New Cholesterol Drug (PFE, AMGN)

    November 2, 2016
    Pfizer will take a 4-cent-a-share charge in its 4Q earnings after scrapping its new cholesterol drug.
  32. Pfizer Caught In Drug Price Maelstrom (PFE)

    November 1, 2016
    Dow component Pfizer is losing ground after missing quarterly estimates and headed into a key test at long-term support near ...
  33. The Biggest Mergers & Acquisitions In The U.S.

    October 23, 2016
    M&A is a daily part of the American business world. They're based on the principle that "One plus one equals three," i.e. ...
  34. What Has Alan Schwartz Done for Guggenheim?

    October 11, 2016
    The former Bear Stearns CEO has worked to transform Guggenheim Partners' reputation, developing an investment bank from scratch.
  35. Pfizer's Kidney Drug Faces a New Rival (EXEL, PFE)

    October 11, 2016
    Pfizer finds new indications for using its kidney cancer drug, Sutent, as it faces imminent competition from Exelixis's treatment,
  36. High Valuations Hammer Dividend Stocks (AES, EXC)

    October 10, 2016
    Investors have been fleeing dividend stocks with high valuations, but strong opportunities still exist.
  37. Pfizer Sells Hospira Device Unit to ICU Medical

    October 7, 2016
    Pharmaceutical giant Pfizer (NYSE: PFE) will soon be a bit smaller: The company has inked an agreement to sell its Hospira ...
  38. Pfizer to Sell Its Aging Headquarters (PFE)

    October 6, 2016
    Pfizer aims to follow a number of big pharmaceutical companies in moving to modern offices.
  39. Pfizer Sells Infusion Therapy Business (PFE)

    October 6, 2016
    Hospira Infusion Systems will make ICU Medical a leader in the infusion therapy space. The deal could mean better efficiency ...
  40. Most Profitable Health Care Companies of 2016 (GILD, JNJ)

    September 15, 2016
    All four of the most profitable health care companies listed on U.S. exchanges reported net income exceeding $2 billion during ...
  41. Understanding Pfizer's Capital Structure (PFE)

    September 6, 2016
    Pfizer has managed to return capital with dividends and share buybacks under limited debt use while the business faced declining ...
  42. Top Value Stocks of 2016 (URBN, PG)

    August 29, 2016
    Remember that value stocks are not always trading near their 52-week lows. Focus on the five key fundamentals for finding ...
  43. Pfizer Inks a $1.6 Billion Deal with AstraZeneca

    August 25, 2016
    In light of its recent acquisition activity, Pfizer's (NYSE: PFE) latest asset purchase might seem small, but it's nevertheless ...
  44. Top 6 Pharmaceutical Companies Globally

    August 23, 2016
    Johnson & Johnson leads the pack in both market cap and revenue.
  45. American Funds Shedding Dividend Payers for Growth (BABA, MO)

    August 23, 2016
    American Funds, with $1.3T in AUM, is shifting towards a growth strategy.
  46. Top 10 Shareholders of Pfizer (PFE)

    August 23, 2016
    As of 2016, approximately 72% of Pfizer's 6.19 billion outstanding shares are owned by [mutual funds] and institutional investors.
  47. Pfizer Acquires Medivation for $14 Billion (PFE, MDVN)

    August 21, 2016
    Pfizer has agreed to pay $81.50 per share for Medivation, implying a premium value compared with the $52.50 offer made by ...
  48. Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)

    August 19, 2016
    The collapse of the planned merger of Pfizer and Allergan triggered major waves in stock holdings among the country's top ...
  49. Who Is Driving Pfizer's Management Team? (PFE)

    August 19, 2016
    Pfizer Inc.'s management team is led by Ian C. Read, Frank D'Amelio and Freda C. Lewis-Hall, all veterans with decades of ...
  50. Allergan Features Prominently in Q2 2016 (AGN, PFE)

    August 17, 2016
    13F filings from top investors show that the pharmaceutical company was a big mover in Q2.
  51. JANA Partners Invests in Time Inc., Exits Pfizer (TIME, PFE)

    August 16, 2016
    JANA Partners enters into a new stake in Time Inc. What could it reveal about the hedge fund's future plans?
  52. Pfizer: 7 Secrets You Didn't Know (PFE)

    August 8, 2016
    The history of Pfizer is more interesting than you know, learn some little-known facts about the pharmaceuticals company ...
  53. Allergan's Q2 Earnings Beat Boosted by Botox

    August 8, 2016
    With the failed Pfizer merger out of the way, Allergan appears focused and is looking once again to maximize growth in its ...
  54. Pfizer Stock Trades Ex-Dividend (PFE)

    August 2, 2016
    Shares declined Tuesday, falling more than 2% despite the company reporting Q2 results that beat Wall Street estimates on ...
  55. Pfizer's Q2 Earnings, Revenue Beat Not Good Enough (PFE)

    August 2, 2016
    Pfizer shares are falling more than 2% despite the company reporting Q2 earnings results that beat Wall Street estimates ...
  56. Pfizer Price Levels To Watch After Earnings (PFE)

    August 1, 2016
    Pfizer has rallied to a 12-year high and could add to gains after Tuesday's earnings report but is extremely overbought and ...
  57. Pfizer Earnings Coming Up: What to Expect? (PFE)

    August 1, 2016
    Wall Street expects another solid quarter for Pfizer, which has topped consensus estimates on both the top and bottom lines ...
  58. Top 5 Corporate Donors in Big Pharma (GILD, MRK)

    July 29, 2016
    Gilead Sciences, Merck and Pfizer were among the biggest corporate cash donors from the drug and health care sector last ...
  59. Pfizer Exits Brazil: Teva Is Suitor (PFE, TEVA)

    July 29, 2016
    Pfizer is planning to exit the Brazilian market as it puts its generic drug joint venture stake up for sale. Teva and Mylan ...
  60. Pfizer, Celgene Pursue Medivation (PFE, CELG)

    July 6, 2016
    Sanofi isn't the only one interested in Medivation. Pfizer and Celgene also signed confidentiality agreements.
  61. Why Pfizer Just Bet $350 Million On China (PFE)

    June 29, 2016
    The drug giant announced plans to invest $350 million on a China-based plant for biotechnology drugs.
  62. Pfizer to Build $350M Biotech Center in China (PFE)

    June 28, 2016
    Pfizer Inc. is investing $350M to build its first biotech center in Asia. What’s the real value proposition for Pfizer beyond ...
  63. Pfizer Stock Rises Despite Price Target Cut (PFE)

    June 21, 2016
    Shares of Pfizer rose as much as 1.37% Monday, reaching a session high of $34.69 even though the drug giant saw its price ...
  64. Oracle Scores Another Cloud Services Win

    June 20, 2016
    By virtually every measure, the cloud market is poised to explode in the coming months and years. One of the fastest-growing ...
  65. 3 Mutual Funds Poised to Perform in the Future (VGENX, FSPHX)

    June 19, 2016
    Learn about sector weightings in growth mutual funds versus the benchmark and how three funds are positioned to profit from ...
  66. Avoid Betting on These Acquisition Target Stocks (PFE, AGN)

    June 16, 2016
    Many target stocks high on acquirers list are trading at deep discounts. Here’s why investors should avoid them.
  67. Is Investment Banking Peaking? (PFE, AGN)

    June 15, 2016
    Learn about the numerous challenges facing investment banking and explore whether the industry is peaking.
  68. How M&A Breakups Are Hurting Investment Banks' Profits (PFE, ...

    June 14, 2016
    Discover what happens when mergers and acquisitions fail. Learn about three major deals that have fallen through in 2016 ...
  69. The Share Buyback Report: Health Care Sector (PFE, JNJ)

    June 3, 2016
    Analyze health care sector share repurchase data to identify trends. Determine which factors influence volume and which companies ...
  70. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  71. 5 Companies With Huge Cash Flow (AAPL,VZ,MSFT,WMT)

    June 1, 2016
    These five companies have major cash flow which makes them good long-term bets.
  72. Allergan Stock Rises on Carl Icahn's Stake (AGN, PFE)

    June 1, 2016
    The Botox maker got a much-needed dose of confidence Tuesday when the market learned that activist investor Carl Icahn had ...
  73. 3 ETFs Affected by the Failed Pfizer-Allergan Merger (PFE, AGN)

    May 28, 2016
    Discover three ETFs that were affected by the failed Pfizer and Allergan acquisition, and learn about the performances and ...
  74. VHT: Vanguard Health Care ETF Performance Analysis

    May 26, 2016
    Discover how the Vanguard Health Care ETF performed through bear and bull markets, and learn which holding is trouncing the ...
  75. Biotech ETFs: Why Valeant May Cause Contagion Risk (VRX)

    May 26, 2016
    Learn about Valeant Pharmaceutical's scandal that caused its stock to plunge over 90%, and why biotech ETF investors should ...
  76. CF Industries Drops Planned Purchase of OCI

    May 24, 2016
    A federal crackdown on tax inversion mergers has effectively killed a planned acquisition by fertilizer maker CF Industries' ...
  77. Pfizer Bets Big on Eczema With Anacor Acquisition

    May 23, 2016
    Pfizer seems to have made the right bet on Anacor to capture the present day $4 billion eczema medicine market.
  78. XenoPort Stock Rises Nearly 60% on Takeover News

    May 23, 2016
    It's a fine time to be a shareholder in biotech company XenoPort (NASDAQ: XNPT). The company revealed Monday that it has ...
  79. Pfizer Buys Anacor Pharmaceuticals For $5.2B (PFE, ANAC)

    May 17, 2016
    Pfizer, which last month ended its bid for Allergan, is looking to capitalize on Anacor's experimental gel used to treat ...
  80. Pfizer to Pay 55% Premium to Acquire Anacor

    May 16, 2016
    The share price of biotech company Anacor Pharmaceuticals (NASDAQ: ANAC) rose by nearly 60% Monday following news that it ...
  81. Allergan Stock Falls to New Low Ahead of Earnings (AGN, PFE)

    May 9, 2016
    Wall Street expects the maker of cosmetic injection Botox to deliver year-over-year declines in both revenue and profits.
  82. Franklin Income Performance Case Study (FKINX)

    May 3, 2016
    Learn about the Franklin Income Fund's history, trends and performance for each quarter over the past decade.
  83. Pfizer Stock Rises Ahead of Earnings (PFE, AGN)

    May 2, 2016
    It turns out Pfizer might not have needed Allergan after all, given that PFE shares have surged 9% and 7.3% in the respective ...
  84. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  85. Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)

    April 27, 2016
    Discover how to analyze which of these top five key global health care technology industry players best suit your portfolio ...
  86. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  87. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  88. Singer Gets Better End of AGN-PFE Deal Implosion

    April 12, 2016
    Paul Singer increased his stake in Allergen by 204.75% in the fourth quarter. How will this impact his portfolio since the ...
  89. Pfizer CEO: Let Us Invest in the U.S. (AGN, PFE)

    April 7, 2016
    Ian Read, Chairman and CEO of Pfizer, published an op-ed in the Wall Street Journal Wednesday, in which he defended the logical ...
  90. Allergan's Fall Hits Hedge Funds Hard (AGN, PFE)

    April 6, 2016
    When shares in Allergan dropped 14.8% to $236.55 on Tuesday, not everyone realized how much – and how many – hedge funds ...
  91. Fidelity Capital & Income Fund's Top 5 Holdings Analysis (FAGIX)

    April 6, 2016
    Evaluate the top five holdings of the Fidelity Capital & Income Fund, and study the basics and recent performance of the ...
  92. Pfizer Withdraws Merger Bid With Allergan (AGN, PFE)

    April 6, 2016
    Pfizer has come to realize the U.S. Treasury Department's new stance with inversions: "Over my dead body."
  93. Allergan Crushed as Tax Inversion Rules Threaten PFE Deal (AGN, ...

    April 5, 2016
    Given the army of lawyers, not to mention lobbyists, on their respective payrolls, Allergen and Pfizer are not likely to ...
  94. The Most Shorted Stocks and ETF (PFE,SPY,CHK,S)

    March 29, 2016
    These stocks and ETF are heavily shorted and have been rallying at breakneck speed. Will it continue?
  95. Pfizer Short Interest Continues to Rise (PFE)

    March 29, 2016
    Dating back to March 2015 the only ones to have made money on PFE stock have been the short sellers. Do they know something ...
  96. Portfolio Trends in 2016 (VGHCX)

    March 25, 2016
    Evaluate the composition of the Vanguard Health Care Fund, and study how the fund's makeup has evolved over the previous ...
  97. 3 S&P 500 Stocks to Sell Short at the 50-Day EMA

    March 21, 2016
    The 50-day EMA works well with other indicators to identify short sale opportunities with market laggards.
  98. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  99. 4 Defensive ETFs Worth Your While (VHT, PGX)

    March 19, 2016
    Find out which top exchange-traded funds (ETFs) would be well worth your consideration when deploying a defensive investment ...
  100. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  • Showing 1-100 of 184 items
  • 1
  • 2
  • >>